ARVs Stories

KEMSA releases ARVs targeting one million HIV patients after concerns over US aid cuts
Maureen Kinyanjui  |  Mar 15, 2025

The supplies will be distributed through a partnership with the Mission for Essential Drugs and Supplies, ensuring their efficient delivery to those i...

Cote d'Ivoire: care for HIV/AIDS fully guaranteed despite suspension of U.S. aid
XINHUA  |  Mar 06, 2025

At the beginning of February, U.S. President Donald Trump announced the closure of the U.S. Agency for International Development (USAID), which in 202...

Kenya faces HIV treatment crisis as only six-month supply of ARV drugs remaining
Maureen Kinyanjui  |  Feb 28, 2025

The freeze has also affected about 41,000 workers, mainly in the health sector, with counties struggling to absorb them.

Over 35,000 jobs lost, 150 clinics shut down as USAID freeze hits Kenya
Charles Adinda  |  Feb 13, 2025

With Kenyan civil societies calling for increased domestic funding to ensure essential health services continue uninterrupted,  the government now fac...

Kenya to use Sh28 billion annually on HIV programmes as foreign aid policies change
Lucy Mumbi  |  Feb 07, 2025

With potential shifts in US aid strategies, Kenya needs to prepare for possible reductions or redirection of donor contributions.

No ARV shortage expected despite US funding cuts, government says
Lucy Mumbi  |  Jan 29, 2025

Health officials said they are confident that there are enough ARVs to cater to over 1.4 million patients in the country.

Childhood in Shadows: Growing up with HIV and a world that doesn't understand
Charity Kilei  |  Dec 21, 2024

Joy contracted HIV from her mother, and her childhood was marked by frequent hospital visits and seminars that painfully underscored her condition.

Mother-to-child HIV transmission rates in Kenya drop, but challenges remain
Maureen Kinyanjui  |  Nov 21, 2024

Despite this progress, experts warn that the current rates are still too high.

Breakthrough in HIV prevention anew PrEP injection offers complete protection for young women
Charity Kilei  |  Jul 04, 2024

The trial, known as the Purpose 1 trial, involved 5,000 participants across multiple sites and compared the efficacy of lenacapavir with two other PrE...

Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.